查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1349396

生物技术 API 製造服务市场 - 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Biotech API Manufacturing Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 105 Pages | 商品交期: 2-10个工作天内

价格

生物技术 API 製造服务市场 - 报告范围

TMR 关于全球生物技术 API 製造服务市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球生物技术 API 的收入2017- 2031 年期间的製造服务市场，以2023 年为基准年，2031 年为预测年。该报告也提供了2023年至2031年全球生技API製造服务市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解生物技术 API 製造服务市场。

市场概况
2023年市场价值 389 亿美元
2031 年市场价值 730 亿美元
复合年增长率 0.071%

该报告深入探讨了全球生物技术 API 製造服务市场的竞争格局。全球生物技术 API 製造服务市场的主要参与者已经确定，并且每个参与者都根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球生物技术 API 製造服务市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 生技产业原料药製造服务概况
  • 监管场景：按地区
  • 价值链分析
  • COVID-19 大流行对产业的影响（价值炼和短期/中期/长期影响）

第 6 章：全球市场分析与预测：按服务类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依服务类型，2017-2031
    • API 製程开发与製造
    • 分析测试和品质控制
    • 监管支持
    • 规模化和商业化製造
  • 市场吸引力分析：按服务类型

第 7 章：全球市场分析与预测：按营运规模

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依业务规模，2017-2031
    • 小型
    • 中等规模
    • 大规模
  • 市场吸引力分析：按经营规模

第 8 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 9 章：北美市场分析与预测

第 10 章：欧洲市场分析与预测

第 11 章：亚太市场分析与预测

第 12 章：拉丁美洲市场分析与预测

第 13 章：中东和非洲市场分析与预测

第 14 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分，2022 年
  • 公司简介
    • Lonza Group Ltd.
    • WuXi AppTec Co., Ltd.
    • Boehringer Ingelheim Biopharmaceuticals GmbH (Boehringer Ingelheim International GmbH)
    • CordenPharma International
    • Sterling Pharma Solutions
    • AbbVie, Inc.
    • Hikal Ltd.
    • Almac Group
    • FUJIFILM Diosynth Biotechnologies
    • Abzena Ltd
    • Regis Technologies, Inc.
    • Rentschler Biopharma SE
    • Catalent, Inc.
Product Code: TMRGL2336

Biotech API Manufacturing Services Market - Scope of Report

TMR's report on the global biotech API manufacturing services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global biotech API manufacturing services market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global biotech API manufacturing services market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the biotech API manufacturing services market.

Market Snapshot
Market Value in 2023US$ 38.9 Bn
Market Value in 2031US$ 73 Bn
CAGR7.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global biotech API manufacturing services market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global biotech API manufacturing services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global biotech API manufacturing services market.

The report delves into the competitive landscape of the global biotech API manufacturing services market. Key players operating in the global biotech API manufacturing services market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global biotech API manufacturing services market profiled in this report.

Key Questions Answered in Global Biotech API Manufacturing Services Market Report:

  • What is the sales/revenue generated by biotech API manufacturing services across all regions during the forecast period?
  • What are the opportunities in the global biotech API manufacturing services market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Biotech API Manufacturing Services Market - Research Objectives and Research Approach

The comprehensive report on the global biotech API manufacturing services market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global biotech API manufacturing services market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global biotech API manufacturing services market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Biotech API Manufacturing Services Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Biotech API Manufacturing Services Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Overview of API Manufacturing Services in Biotechnology Industry
  • 5.2. Regulatory Scenario, by Region
  • 5.3. Value Chain Analysis
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Biotech API Manufacturing Services Market Analysis and Forecast, by Service Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Service Type, 2017-2031
    • 6.3.1. API Process Development & Manufacturing
    • 6.3.2. Analytical Testing & Quality Control
    • 6.3.3. Regulatory Support
    • 6.3.4. Scale-up & Commercial Manufacturing
  • 6.4. Market Attractiveness Analysis, by Service Type

7. Global Biotech API Manufacturing Services Market Analysis and Forecast, by Scale of Operations

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Scale of Operations, 2017-2031
    • 7.3.1. Small-scale
    • 7.3.2. Mid-scale
    • 7.3.3. Large-scale
  • 7.4. Market Attractiveness Analysis, by Scale of Operations

8. Global Biotech API Manufacturing Services Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Biotech API Manufacturing Services Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Service Type, 2017-2031
    • 9.2.1. API Process Development & Manufacturing
    • 9.2.2. Analytical Testing & Quality Control
    • 9.2.3. Regulatory Support
    • 9.2.4. Scale-up & Commercial Manufacturing
  • 9.3. Market Value Forecast, by Scale of Operations, 2017-2031
    • 9.3.1. Small-scale
    • 9.3.2. Mid-scale
    • 9.3.3. Large-scale
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Service Type
    • 9.5.2. By Scale of Operations
    • 9.5.3. By Country

10. Europe Biotech API Manufacturing Services Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Service Type, 2017-2031
    • 10.2.1. API Process Development & Manufacturing
    • 10.2.2. Analytical Testing & Quality Control
    • 10.2.3. Regulatory Support
    • 10.2.4. Scale-up & Commercial Manufacturing
  • 10.3. Market Value Forecast, by Scale of Operations, 2017-2031
    • 10.3.1. Small-scale
    • 10.3.2. Mid-scale
    • 10.3.3. Large-scale
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Service Type
    • 10.5.2. By Scale of Operations
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Biotech API Manufacturing Services Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Service Type, 2017-2031
    • 11.2.1. API Process Development & Manufacturing
    • 11.2.2. Analytical Testing & Quality Control
    • 11.2.3. Regulatory Support
    • 11.2.4. Scale-up & Commercial Manufacturing
  • 11.3. Market Value Forecast, by Scale of Operations, 2017-2031
    • 11.3.1. Small-scale
    • 11.3.2. Mid-scale
    • 11.3.3. Large-scale
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. India
    • 11.4.3. Japan
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Service Type
    • 11.5.2. By Scale of Operations
    • 11.5.3. By Country/Sub-region

12. Latin America Biotech API Manufacturing Services Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Service Type, 2017-2031
    • 12.2.1. API Process Development & Manufacturing
    • 12.2.2. Analytical Testing & Quality Control
    • 12.2.3. Regulatory Support
    • 12.2.4. Scale-up & Commercial Manufacturing
  • 12.3. Market Value Forecast, by Scale of Operations, 2017-2031
    • 12.3.1. Small-scale
    • 12.3.2. Mid-scale
    • 12.3.3. Large-scale
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Service Type
    • 12.5.2. By Scale of Operations
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Biotech API Manufacturing Services Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Service Type, 2017-2031
    • 13.2.1. API Process Development & Manufacturing
    • 13.2.2. Analytical Testing & Quality Control
    • 13.2.3. Regulatory Support
    • 13.2.4. Scale-up & Commercial Manufacturing
  • 13.3. Market Value Forecast, by Scale of Operations, 2017-2031
    • 13.3.1. Small-scale
    • 13.3.2. Mid-scale
    • 13.3.3. Large-scale
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Service Type
    • 13.5.2. By Scale of Operations
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2022
  • 14.3. Company Profiles
    • 14.3.1. Lonza Group Ltd.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. WuXi AppTec Co., Ltd.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Boehringer Ingelheim Biopharmaceuticals GmbH (Boehringer Ingelheim International GmbH)
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. CordenPharma International
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Sterling Pharma Solutions
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. AbbVie, Inc.
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Hikal Ltd.
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Almac Group
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. FUJIFILM Diosynth Biotechnologies
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview
    • 14.3.10. Abzena Ltd
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. Financial Overview
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview
    • 14.3.11. Regis Technologies, Inc.
      • 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.11.2. Product Portfolio
      • 14.3.11.3. Financial Overview
      • 14.3.11.4. SWOT Analysis
      • 14.3.11.5. Strategic Overview
    • 14.3.12. Rentschler Biopharma SE
      • 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.12.2. Product Portfolio
      • 14.3.12.3. Financial Overview
      • 14.3.12.4. SWOT Analysis
      • 14.3.12.5. Strategic Overview
    • 14.3.13. Catalent, Inc.
      • 14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.13.2. Product Portfolio
      • 14.3.13.3. Financial Overview
      • 14.3.13.4. SWOT Analysis
      • 14.3.13.5. Strategic Overview

List of Tables

  • Table 01: Global Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Service Type, 2017-2031
  • Table 02: Global Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Scale of Operations, 2017-2031
  • Table 03: Global Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 04: North America Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Service Type, 2017-2031
  • Table 05: North America Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Scale of Operations, 2017-2031
  • Table 06: North America Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: Europe Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Service Type, 2017-2031
  • Table 08: Europe Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Scale of Operations, 2017-2031
  • Table 09: Europe Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Asia Pacific Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Service Type, 2017-2031
  • Table 11: Asia Pacific Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Scale of Operations, 2017-2031
  • Table 12: Asia Pacific Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 13: Latin America Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Service Type, 2017-2031
  • Table 14: Latin America Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Scale of Operations, 2017-2031
  • Table 15: Latin America Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Middle East & Africa Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Service Type, 2017-2031
  • Table 17: Middle East & Africa Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Scale of Operations, 2017-2031
  • Table 18: Middle East & Africa Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Biotech API Manufacturing Services Market Value Share Analysis, by Service Type, 2022 and 2031
  • Figure 03: Global Biotech API Manufacturing Services Market Attractiveness Analysis, by Service Type, 2022-2031
  • Figure 04: Global Biotech API Manufacturing Services Market Revenue (US$ Mn), by API Process Development & Manufacturing, 2017-2031
  • Figure 05: Global Biotech API Manufacturing Services Market Revenue (US$ Mn), by Analytical Testing & Quality Control, 2017-2031
  • Figure 06: Global Biotech API Manufacturing Services Market Revenue (US$ Mn), by Regulatory Support, 2017-2031
  • Figure 07: Global Biotech API Manufacturing Services Market Revenue (US$ Mn), by Scale-up & Commercial Manufacturing, 2017-2031
  • Figure 08: Global Biotech API Manufacturing Services Market Value Share Analysis, by Scale of Operations, 2022 and 2031
  • Figure 09: Global Biotech API Manufacturing Services Market Attractiveness Analysis, by Scale of Operations, 2022-2031
  • Figure 10: Global Biotech API Manufacturing Services Market Revenue (US$ Mn), by Small-scale, 2017-2031
  • Figure 11: Global Biotech API Manufacturing Services Market Revenue (US$ Mn), by Mid-scale, 2017-2031
  • Figure 12: Global Biotech API Manufacturing Services Market Revenue (US$ Mn), by Large-scale, 2017-2031
  • Figure 13: Global Biotech API Manufacturing Services Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 14: Global Biotech API Manufacturing Services Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 15: North America Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 16: North America Biotech API Manufacturing Services Market Value Share Analysis, by Service Type, 2022 and 2031
  • Figure 17: North America Biotech API Manufacturing Services Market Attractiveness Analysis, by Service Type, 2022-2031
  • Figure 18: North America Biotech API Manufacturing Services Market Value Share Analysis, by Scale of Operations, 2022 and 2031
  • Figure 19: North America Biotech API Manufacturing Services Market Attractiveness Analysis, by Scale of Operations, 2022-2031
  • Figure 20: North America Biotech API Manufacturing Services Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 21: North America Biotech API Manufacturing Services Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 22: North America Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 23: Europe Biotech API Manufacturing Services Market Value Share Analysis, by Service Type, 2022 and 2031
  • Figure 24: Europe Biotech API Manufacturing Services Market Attractiveness Analysis, by Service Type, 2022-2031
  • Figure 25: Europe Biotech API Manufacturing Services Market Value Share Analysis, by Scale of Operations, 2022 and 2031
  • Figure 26: Europe Biotech API Manufacturing Services Market Attractiveness Analysis, by Scale of Operations, 2022-2031
  • Figure 27: Europe Biotech API Manufacturing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 28: Europe Biotech API Manufacturing Services Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 29: Europe Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 30: Asia Pacific Biotech API Manufacturing Services Market Value Share Analysis, by Service Type, 2022 and 2031
  • Figure 31: Asia Pacific Biotech API Manufacturing Services Market Attractiveness Analysis, by Service Type, 2022-2031
  • Figure 32: Asia Pacific Biotech API Manufacturing Services Market Value Share Analysis, by Scale of Operations, 2022 and 2031
  • Figure 33: Asia Pacific Biotech API Manufacturing Services Market Attractiveness Analysis, by Scale of Operations, 2022-2031
  • Figure 34: Asia Pacific Biotech API Manufacturing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 35: Asia Pacific Biotech API Manufacturing Services Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 36: Asia Pacific Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 37: Latin America Biotech API Manufacturing Services Market Value Share Analysis, by Service Type, 2022 and 2031
  • Figure 38: Latin America Biotech API Manufacturing Services Market Attractiveness Analysis, by Service Type, 2022-2031
  • Figure 39: Latin America Biotech API Manufacturing Services Market Value Share Analysis, by Scale of Operations, 2022 and 2031
  • Figure 40: Latin America Biotech API Manufacturing Services Market Attractiveness Analysis, by Scale of Operations, 2022-2031
  • Figure 41: Latin America Biotech API Manufacturing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Latin America Biotech API Manufacturing Services Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 43: Latin America Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 44: Middle East & Africa Biotech API Manufacturing Services Market Value Share Analysis, by Service Type, 2022 and 2031
  • Figure 45: Middle East & Africa Biotech API Manufacturing Services Market Attractiveness Analysis, by Service Type, 2022-2031
  • Figure 46: Middle East & Africa Biotech API Manufacturing Services Market Value Share Analysis, by Scale of Operations, 2022 and 2031
  • Figure 47: Middle East & Africa Biotech API Manufacturing Services Market Attractiveness Analysis, by Scale of Operations, 2022-2031
  • Figure 48: Middle East & Africa Biotech API Manufacturing Services Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 49: Middle East & Africa Biotech API Manufacturing Services Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 50: Middle East & Africa Biotech API Manufacturing Services Market Value (US$ Mn) Forecast, 2017-2031